Roflupram, a novel phosphodiesterase 4 inhibitor, inhibits lipopolysaccharide-induced neuroinflammatory responses through activation of the AMPK/Sirt1 pathway
Roflupram, a novel phosphodiesterase 4 inhibitor, inhibits lipopolysaccharide-induced neuroinflammatory responses through activation of the AMPK/Sirt1 pathway
复制标题
Roflupram 是一种新型磷酸二酯酶 4 抑制剂，通过激活 AMPK/Sirt1 通路抑制脂多糖诱导的神经炎症反应
DOI：
10.1016/j.intimp.2020.107176
复制
发表时间：
2021
影响因子：
5.6
通讯作者：
Wang Haitao
中科院分区：
文献类型：
--
作者：
Li Dan;Xu Jiangping;Qin Yunyun;Cai Ningbo;Cheng Yufang;Wang Haitao
